About Joseph Ravenell:
Joseph Ravenell, MD, MS, is Assistant Professor of Population Health and Medicine at NYU School of Medicine. He is a core member of the Center for Healthful Behavior Change, a board-certified internist and hypertension specialist with a strong track record of NIH funding to improve cardiovascular disease in diverse populations. He is Principle Investigator (PI) or co-PI of 3 community-based randomized trials: 1) a National Heart, Lung, Blood Institute R01 (1R01HL096946) grant to test community-based strategies to improve blood pressure control and colon cancer screening in 24 black churches in Harlem; 2) a National Institute for Minority Health and Health Disparities P60 project (1P60MD003421, Proj 2) to improve blood pressure control and cancer screening in black barbershops; and 3) a CDC-funded U48 grant (1U48 DP002671) to test the comparative effectiveness of two interventions to increase blood pressure control among black men in New York City.
Why Dr. Joseph Ravenell?
Using unexpected channels like the pulpit and the barber’s chair, Joseph Ravenell delivers basic health care information to an at-risk demographic — African-American men.
Dr. Ravenell is a current recipient of the Harold Amos Medical Faculty Development Award from the Robert Wood Johnson Foundation to study a physician-level intervention to improve global cardiovascular risk in black men. He also received the American Heart Association Pharmaceutical Roundtable Career Development Award for Implementation Research for a project focused on improving guideline-concordant hypertension management among physicians within New York City’s municipal health system. He is co-PI of an NIA-funded RC4 grant to examine the impact of a behavioral economics intervention to improve adherence to clinical lipid-lowering guidelines among physicians in a New York City primary care practice. In parallel with developing unique expertise in multi-level cardiovascular and cancer research, Dr. Ravenell has become a leader in hypertension clinical care and training. He is certified as a Specialist in Clinical Hypertension by the American Society of Hypertension, and was elected as an inaugural Fellow of the American Society of Hypertension.
Dr. Ravenell co-founded the Bellevue Hospital Resistant Hypertension Program, and established the first NYU Hypertension and Lipidology Fellowship designed to train physicians in the management of high-risk hypertension and community-based behavioral cardiovascular research. Through research, clinical care and training, Dr. Ravenell continually cultivates a multi-level approach to improving cardiovascular disease and cancer-related population health.